Relative Bioavailability Trial of L-Praziquantel in Healthy Volunteers

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
This is a phase I, open-label, randomized, 5 period, crossover, single-center trial. The purpose of this trial is to assess the relative bio-availability of L-praziquantel (L-PZQ \[MSC2499550A\]) oral dispersible tablet (ODT) formulation (150 milligram \[mg\]) versus the current marketed racemate praziquantel (PZQ) (Cysticide® 500 mg) formulation in healthy male volunteers under fed conditions.
Epistemonikos ID: 74306fff8b81761977d6bd9bdc513a2addaf200c
First added on: May 12, 2024